Association of germline variant status with therapy response in high-risk early-stage breast cancer: a secondary analysis of the geparOcto randomized clinical trial - Pohl-Rescigno, Esther; Hauke, Jan; Loibl, Sibylle; Möbus, Volker; Denkert, Carsten; Fasching, Peter A.; Kayali, Mohamad; Ernst, Corinna; Weber-Lassalle, Nana; Hanusch, Claus; Tesch, Hans; Müller, Volkmar; et al. (JAMA oncology, 2020)
Gesehen am 01.04.2021